What Is DACOGEN (decitabine)?
DACOGEN is a hypomethylating agent. Ask your healthcare provider if you have questions or want to know more about hypomethylating agents.
DACOGEN is a prescription medicine for patients with MDS, including previously treated and untreated MDS and de novo (cause unknown) and secondary (treatment-related) MDS of all French-American- British (FAB) subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System (IPSS) groups.
To learn more about the FAB subtypes or the IPSS groups, talk with your healthcare provider. Your healthcare provider may be able to tell you what type of MDS you have and is your best source for information about your treatment or health.
The information on this website does not replace direction from your healthcare provider. Call your healthcare provider right away if you have any questions at any time during your treatment with DACOGEN.